Skip to main content
Clinical Trials/JPRN-UMIN000011384
JPRN-UMIN000011384
Completed
Phase 1

A prospective study to investigate the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei - PMP study

ational Center for Global Health and Medicine0 sites75 target enrollmentOctober 1, 2013

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
pseudomyxoma peritonei
Sponsor
ational Center for Global Health and Medicine
Enrollment
75
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 1, 2013
End Date
September 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Center for Global Health and Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patient who has a history of multiple cancers within 5 years before registration, with the exception of carcinoma in situ and a disease equivalent of intramucosal carcinoma. 2\) Patient who is associated with unstable angina pectoris that occurred or worsened within 3 weeks before registration, or patient with a history of cardiac infarction that developed within 6 months before registration. 3\) Patient with serious diseases including uncontrolled congestive cardiac failure and abnormal cardiac rhythm. 4\) Patient who is associated with or has a history of either fibroid lung or interstitial pneumonia or both. Patient with imaging findings suggestive of the diseases. 5\) Patient who is pregnant or breast feeding, or who refuses to use appropriate birth control. 6\) Patient whose consent is suspicious in terms of his/her mental and legal state. 7\) Patient who is considered by the investigator to be unsuitable for enrollment.

Outcomes

Primary Outcomes

Not specified

Similar Trials